A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

This study tests a new add-on treatment called GB-0895 for people with severe asthma that is not well controlled even with multiple inhalers. It is part of the SOLAIRIA-2 trial, looking at whether GB-0895 reduces asthma attacks and improves lung function. **You may be eligible if...** - You are between 12 and 80 years old - You have had asthma diagnosed for at least 2 years - You have been on medium-to-high dose inhaled steroids for at least 12 months and at least one additional controller inhaler (like a long-acting bronchodilator) for at least 3 months - You have had at least 2 asthma attacks in the past year that needed oral steroids - Your lung function tests (FEV1) are below normal levels - You weigh at least 40 kg **You may NOT be eligible if...** - You had a significant asthma attack in the past 12 weeks - You have another lung disease (such as COPD, bronchiectasis, or pulmonary fibrosis) - You are currently receiving another biologic (injectable) asthma treatment - You are pregnant or breastfeeding - You have a severe immune system disorder Talk to your doctor to see if this trial is right for you.